Propofol differentially inhibits the release of glutamate, γ-aminobutyric acid and glycine in the spinal dorsal horn of rats

Document Type: Original Article

Authors

1 Department of Anesthesiology, Chinese People Liberation Army (PLA) General Hospital, Beijing 100853, China

2 Department of Orthopedics, Chinese People Liberation Army (PLA) General Hospital, Beijing 100853, China

3 Department of Pharmacology, Institution of Pharmacology and Toxicology, 100039, China

Abstract

Objective(s): Propofol (2, 6-diisopropylphenol) is an intravenous anesthetic that is commonly used for the general anesthesia. It is well known that the spinal cord is one of the working targets of general anesthesia including propofol. However, there is a lack of investigation of the effects of propofol on spinal dorsal horn which is important for the sensory transmission of nociceptive signals. The objective of this study was to investigate the effects of increasing dosage of propofol on the release of glutamate (Glu), γ-aminobutyric acid (GABA) and glycine (Gly) in the spinal dorsal horn.
Materials and Methods: The efflux of Glu, GABA or Gly in the spinal dorsal horn of rats was detected using transverse spinal microdialysis under an awake condition and various depths of propofol anesthesia. The infusion rates of propofol were, in order, 400 µg/(kg·min), 600 µg/(kg·min) and 800 µg/(kg·min), with a 20 min infusion period being maintained at each infusion rate.
Results: Propofol decreased the glutamate efflux within spinal dorsal horn in a dose-dependent manner, and the maximum decrease was 56.8 ± 6.0% at high-dose propofol infusion producing immobility. The inhibitory GABA and Gly efflux was also decreased about 15–20% at low-dose propofol infusion only producing sedation, but did not continue to drop with higher doses of propofol.
Conclusion: Propofol decreased both excitatory and inhibitory amino acids efflux in spinal dorsal horn, and the preferential suppression of the excitatory amino acid might be associated with the analgesic effect of propofol.

Keywords


1.Collins JG, Kendig JJ, Mason P. Anesthetic actions within the spinal cord: Contributions to the state of general anesthesia. Trends Neurosci 1995; 18: 549 -553.

2.Kungys G, Kim J, Jinks SL, Atherley RJ, Antognini JF. Propofol produces immobility via action in the ventral horn of the spinal cord by a GABAergic mechanism. Anesth Analg 2009; 108: 1531-1537.

3.Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997; 14: 2-31.

4.Takasusuki T1, Yamaguchi S, Hamaguchi S, Yaksh TL. Effects of general anesthetics on substance P 

release and c-Fos expression in the spinal dorsal horn. Anesthesiology. 2013; 119: 433-442.

5.Antognini JF, Wang XkW, Piercy M, Carstens E. Propofol directly depresses lumbar dorsal horn neuronal responses to noxious stimulation in goats. Can J Anaesth 2000; 47: 273-279.

6.Takechi K, Carstens MI, Klein AH, Carstens E. The antinociceptive and antihyperalgesic effects of topical propofol on dorsal horn neurons in the rat. Anesth Analg 2013; 116: 932-938.

7.Skilling SR, Smullin DH, Beitz AJ, Larson AA. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neuroehem 1988; 51: 127-132.

8.Sluka KA,Westlund KN. (1992). An experimental arthritis model in rats: dorsal horn aspartate and glutamate increases. Neurosci Lett 145: 141-144.

9.Valtschanoff JG, Phend KD, Bernardi PS, Weinherg RJ, Rustioni A. Amino acid immunocytochemistry of primary afferent terminals in the rat dorsal horn. J Comp Neurol 1994; 346: 237–252.

10.Ataka T1, Kumamoto E, Shimoji K, Yoshimura M. Baclofen inhibits more effectively C-afferent than Adelta-afferent glutamatergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Pain 2000, 86: 273-282.

11.Engelman HS, MacDermott AB. Presynaptic ionotropic receptors and control of transmitter release. Nat Rev Neurosci 2004; 5: 135-145.

12.Ishikawa, T, Marsala, M, Sakabe, T, Yaksh TLl. Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA (A) receptor antagonist. Neuroscience 2000; 95: 781-786.

13.Kleschevnikov AM, Belichenko PV, Gall J, George L, Noshenv MT. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis 2012; 45: 683-691.

14.Manuel NA, Davies CH. Pharmacological modulation of GABA (A) receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. Br J Pharmacol 1998; 125: 1529-1542.

15.Shimizu M, Yamakura T, Tobita T, Okamoto M, Ataka T, et al. Propofol enhances GABAA receptor-mediated presynaptic inhibition in human spinal cord. Neuroreport 2002; 13: 357-360.

16.Yamakura T, Bertaccini E, Trudell JR, Harris RA. Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001; 41:23–51.

17.Lü N, Han M, Yang ZL, Wang YQ, Wu GC, Zhang YQ. Nociceptin/Orphanin FQ in PAG modulates the release of amino acids, serotonin and norepinephrine in the rostral ventromedial medulla and spinal cord in rats. Pain 2010; 148: 414-425.